Protagonist Therapeutics Inc (PTGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 131,121 | 355,643 | 172,568 | 186,727 | 230,527 |
| Marketable Securities | 337,600 | 208,354 | 150,067 | 154,890 | 90,224 |
| Receivables | N/A | 43 | 300,043 | 10,000 | N/A |
| TOTAL | $476,769 | $570,925 | $627,553 | $355,577 | $324,881 |
| Non-Current Assets | |||||
| PPE Net | 2,468 | 1,780 | 1,111 | 1,195 | 1,421 |
| Investments And Advances | 114,560 | 31,447 | 0 | 0 | 1,985 |
| Other Non-Current Assets | 10,060 | 10,477 | 612 | 1,179 | 1,729 |
| TOTAL | $127,088 | $43,704 | $1,723 | $2,374 | $5,135 |
| Total Assets | $603,857 | $614,629 | $629,276 | $357,951 | $330,016 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,049 | 3,629 | 3,510 | 775 | 1,255 |
| Accrued Expenses | 20,739 | 15,175 | 16,487 | 19,358 | 24,809 |
| TOTAL | $44,578 | $41,578 | $39,910 | $21,274 | $27,867 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 19,696 | 20,124 | 16,125 | N/A | N/A |
| Other Non-Current Liabilities | 10,855 | 10,971 | 0 | 0 | 0 |
| TOTAL | $27,364 | $31,727 | $28,922 | $N/A | $N/A |
| Total Liabilities | $71,942 | $73,305 | $68,832 | $21,274 | $27,867 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 59,598 | 58,905 | 58,652 | 58,275 | 57,678 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -472,196 | -438,986 | -408,370 | -615,710 | -643,045 |
| Other shareholders' equity | 1,336 | -249 | -229 | -105 | -170 |
| TOTAL | $531,915 | $541,324 | $560,444 | $336,677 | $302,149 |
| Total Liabilities And Equity | $603,857 | $614,629 | $629,276 | $357,951 | $330,016 |